Alzheimer's disease (AD) is an incurable neurodegenerative disease characterized by
progressive decline of cognitive abilities. Amyloid beta peptides (Aβ), Tau proteins and the …

The review brings a comprehensive survey of recent developments and applications of high
performance capillary and microchip electroseparation methods (zone electrophoresis …

In this study, single-step magnetic-beads based immunoassays was developed and for the
first time adapted to microfluidic droplet operation for sequential determination of well …

Background A reduced amyloid-β (Aβ) 42/40 peptide ratio in blood plasma represents a
peripheral biomarker of the cerebral amyloid pathology observed in Alzheimer's disease …

Background The quantification of amyloid-beta (Aβ) peptides in blood plasma as potential
biomarkers of Alzheimer's disease (AD) is hampered by very low Aβ concentrations and the …

The neuropathological hallmarks of Alzheimer's disease include extracellular neuritic
plaques and neurofibrillary tangles. The neuritic plaques contain β-amyloid peptides (Aβ …

Over the last two decades, the group of techniques called affinity probe CE has been widely
used for the detection and the determination of several types of biomolecules with high …

A novel and sensitive sandwich-type photoelectrochemical (PEC) immunosensor was
developed for the quantitative detection of β-amyloid protein (Aβ). A ITO electrode was …

Background The deposition of neurotoxic amyloid-β (Aβ) peptides in plaques in the brain
parenchyma and in cerebral blood vessels is considered to be a key event in Alzheimer's …

Aims The deposition of amyloid‐β (Aβ) peptides in the form of extracellular plaques in the
brain represents one of the classical hallmarks of Alzheimer's disease (AD). In addition to …